Related Experiment Video
Updated: Sep 11, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
376
Stable Breast Cancer Prognosis.
IEEE Transactions on Computational Biology and Bioinformatics
|August 14, 2025
Summary
This study introduces Deep Global Balancing Cox regression (DGBCox), a new method for stable breast cancer prognosis. DGBCox ensures accurate predictions even when data distributions shift, outperforming existing models.
Area of Science:
- Oncology
- Bioinformatics
- Machine Learning
Background:
- Accurate breast cancer prognosis is crucial for effective treatment and management.
- Existing prognostic models often assume data distribution consistency, which is frequently violated due to cancer heterogeneity and varied data collection environments.
- Data distribution shifts can compromise the stability and accuracy of current breast cancer prediction models.
Purpose of the Study:
- To develop a novel method for stable breast cancer prognosis that addresses data distribution shifts.
- To improve the reliability and accuracy of prognostic predictions in the presence of heterogeneous data.
Main Methods:
- The proposed Deep Global Balancing Cox regression (DGBCox) model leverages causal inference theory.
- High-dimensional gene expression data is transformed into latent representations using a deep autoencoder neural network.
- Causality-based balancing of latent representations is performed, followed by the selection of causal latent features for prognosis.
Main Results:
- DGBCox was applied to 12 diverse breast cancer datasets.
- The model demonstrated superior performance compared to benchmark methods.
- Results indicate enhanced prediction accuracy and stability under data distribution shifts.
Conclusions:
- DGBCox offers a robust solution for stable breast cancer prognosis, particularly in scenarios with data distribution shifts.
- The method's foundation in causal inference contributes to more reliable prognostic predictions.
- DGBCox represents a significant advancement in applying machine learning to complex cancer data.
Related Concept Videos
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K

